- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations.
Aarti Drugs filed its FY26 Sustainability Report. The company temporarily stopped a chlorosulfonation process at its T-150 unit following an HCl gas leak, per MPCB directives. It reported a Turnover of ₹2,260.39 Cr, boosting R&D/Capex for environmental and social improvements, including ZLD at 10 API facilities.